Vitis vinifera cells grown in vitro respond to methyl jasmonate (MeJa) with enhancement of phytoalexin accumulation. MeJa added during the first half of the exponential growth phase increased the intracellular accumulation of stilbenes, mainly (Z)- and (E)-piceid (3,5,4'-trihydroxystilbene-3-O-P-glucoside), in strains grown in either maintenance medium or polyphenol inductive medium. Plant cell cultures were used to produce isotopically (C-13) labeled stilbenes by addition of C-13 phenylalanine at different time intervals and in various concentrations. Incorporation of C-13 phenylalanine into stilbenes was measured by EA-IRMS, and three successive 2-mM phenylalanine additions provided the best result (66%). This allowed production of C-13 labeled Vitis vinifera phenolic compounds for investigation of their absorption in humans.
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Fauconneau, B
;
WaffoTeguo, P
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
WaffoTeguo, P
;
Huguet, F
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Huguet, F
;
Barrier, L
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Barrier, L
;
Decendit, A
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Decendit, A
;
Merillon, JM
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Fauconneau, B
;
WaffoTeguo, P
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
WaffoTeguo, P
;
Huguet, F
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Huguet, F
;
Barrier, L
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Barrier, L
;
Decendit, A
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Decendit, A
;
Merillon, JM
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE